FAKTOR-OPTIONSSCHEIN - JOHNSON & JOHNSON Share Price

Certificat

DE000MC3HKC5

Market Closed - Börse Stuttgart 01:16:39 08/06/2024 am IST
3.69 EUR +0.27% Intraday chart for FAKTOR-OPTIONSSCHEIN - JOHNSON & JOHNSON
3 months+16.40%
6 months+11.14%
Date Price Change
07/24/07 3.69 +0.27%
06/24/06 3.68 -0.54%
05/24/05 3.7 +1.65%
04/24/04 3.64 +0.28%
03/24/03 3.63 -1.63%

Delayed Quote Börse Stuttgart

Last update June 08, 2024 at 01:16 am IST

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying JOHNSON & JOHNSON
Issuer Morgan Stanley
WKN MC3HKC
ISINDE000MC3HKC5
Date issued 15/08/2019
Strike 219.7 $
Maturity Unlimited
Parity 18.22 : 1
Emission price 10
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 12.14
Lowest since issue 2.64
Spread 0.01
Spread %0.27%

Company Profile

Johnson & Johnson is one of the world's leading producers of healthcare products. Net sales break down by family of products as follows: - pharmaceutical products (55.4%): drugs intended for the treatment of cardiovascular diseases, oncological diseases, gastro-intestinal illnesses, infectious, immunological, neurological, dermatological diseases, etc.; - medical products and equipment (28.9%): diagnostic systems, orthopedic and gynecological equipment, surgical materials, etc. for use by healthcare professionals; - consumer health products (15.7%): OTC drugs (Tylenol, Sudafed, Benadryl, Zyrtec, Motrin, Nicorette and other brands), health and beauty products (Aveeno, Clean & Clear, Dr. CI:Labo, Neutrogena and OGX), baby care products (Johnson's and Aveeno Baby), oral care products (Listerine), feminine hygiene products (Stayfree and Carefree and o.b.), wound care products (Band-Aid and Neosporin) etc. At the end of 2022, Johnson & Johnson has 89 manufacturing facilities located in the United States (28), North America (9), Europe (27), Africa and Asia/Pacific (25). Net sales are distributed geographically as follows: the United States (51.2%), Europe (24.7%), Asia/Pacific and Africa (17.7%) and other (6.4%).
Sector
-
More about the company

Ratings for Johnson & Johnson

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Johnson & Johnson

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
23
Last Close Price
147.1 USD
Average target price
171.7 USD
Spread / Average Target
+16.75%
Consensus